BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Oncolytics Biotech Inc. To Participate In The Bloom Burton & Co. Healthcare Investor Conference

  April 29, 2016

   · 

  2 min read
• Genetown

  Haemonetics Honored For Delivering ‘World-Class’ Customer Service

  April 29, 2016

   · 

  2 min read
• St. Jude Children’s Research Hospital PLAY LIVE Prize Season Levels-Up On April 29

  April 29, 2016

   · 

  4 min read
• Drug Development

  DURECT Announces Closing Of Public Offering Of Common Stock

  April 29, 2016

   · 

  3 min read
• Janssen-Cilag International NV’s IMBRUVICA (ibrutinib) Receives Positive CHMP Opinion For Expanded Use In Previously Untreated Chronic Lymphocytic Leukaemia Patients

  April 29, 2016

   · 

  9 min read
• BioMidwest

  AbbVie Release: European Medicines Agency Issues Positive Opinion For The Use Of IMBRUVICA (Ibrutinib) As A First-Line Treatment For Chronic Lymphocytic Leukemia Patients

  April 29, 2016

   · 

  11 min read
• Biotech Bay

  European CHMP Adopts Positive Opinion For Gilead’s TAF-Based Single Tablet Regimen Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) For Treatment Of HIV

  April 29, 2016

   · 

  4 min read
• Allergan Receives CHMP Positive Opinion For ENZEPI (Pancrelipase) For Patients With Exocrine Pancreatic Insufficiency (EPI)

  April 29, 2016

   · 

  6 min read
• For New Product Development Meet Reliance At Analytica

  April 29, 2016

   · 

  2 min read
• NightstaRx Reports Long-Term Benefits Of Gene Therapy For Inherited Form Of Progressive Blindness, As Published In The New England Journal Of Medicine

  April 29, 2016

   · 

  3 min read